Skip to main content
. 2020 Apr 14;39(6):1011–1019. doi: 10.1007/s10096-020-03874-z

Table 2.

Clinical and laboratory findings of patients with SARS-CoV-2 infection [13, 39, 41]

Common symptoms Laboratory findings
  Fever 77.4–98.6% Lymphopenia 35.3–82.1%
  Cough 59.4–81.8% Thrombocytopenia 5.0–36.2%
  Fatigue 38.1–69.6% Leukopenia 9.1–33.7%
  Dyspnea 3.2–55.0% Increased CRP 60.7–86.3%
  Myalgia 11.1–34.8% Increased d-dimer 36.4–46.4%
  Sputum production 28.2–56.5% Increased LDH 27.4–75.8%
  Headache 6.5–33.9% Increased CK 8.0–32.5%
Underlying diseases 25.2–50.5% Prolonged prothrombin time 58.0%
Complication Increased ALT 16.1–28.3%
  ARDS 3.4–29.3% Increased AST 22.2–36.7%
  Shock 1.0–8.7% Increased interleulin-6 51.5%
  Acute renal injury 0.5–7.3% Increased serum fenitin 62.6%
  Acute cardiac injury 7.2–12.2% Increased ESR 84.8%
  Secondary infections 9.8% Increased procalcitonin 5.5–11.3%
Increased troponin I 12.2%
Increased creatinine 1.9–9.8%

ARDS, acute respiratory distress syndrome; CRP, C-reactive protein; LDH, lactose dehydrogenase; CK, creatinine kinase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ESR, erythrocyte sedimentation rate